Krispy Kreme will be selling a collection of Doggie Doughnuts designed for dogs in honor of National Dog Day, this Friday, August 26.
The dog treats are described as six all-natural, doughnut-shaped biscuits inspired by classic Krispy Kreme varieties like Strawberry Iced with Sprinkles and Chocolate Glazed.
The six-treat boxes will be available in-store on Friday until they run out.
Krispy Kreme collaborated with the Australian pet treat company Huds and Toke to create these hard-baked cookies using dog-friendly ingredients such as Carob as a chocolate substitute, making them suitable for dogs of any size or age.
Krispy Kreme also clarified that Doggie Doughnuts are intended as snacks and are not formulated to be served as a complete and balanced meal.
The company has created a FAQ page for the treats, which includes additional information such as an ingredient list and nutritional information.
Krispy Kreme will also have a dog accessory available: a limited-edition red Krispy Kreme bandana with a pattern of dogs, bones, and doughnuts, which will be available while supplies last.


Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Want to cut your energy bills? Here’s how five experts are doing it
Asian Currencies Mixed as Aussie Dollar Rises on Hot Inflation
U.S. Unleashes New Iran Sanctions, Targets Oil, Crypto and Trade Networks
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Australia Inflation Beats Forecasts, Raising RBA Rate Hike Risk
Bank of Korea Raises Rates to 3% as Inflation Stays Sticky
US-Canada Tariff War Escalates With 50% Auto Duties
US Stocks Finish Flat as Inflation Data, Nvidia Earnings Keep Investors Cautious
US PCE Inflation Holds at 3.7% as Fed Rate Decision Looms
How to support someone who is grieving: five research-backed strategies
SK Hynix Shares Fall as Workers Reject Wage Deal
US Dollar Rises as Inflation Backs Fed Pause, Canadian Dollar Slides
Trump Buys SpaceX Shares After Record IPO
The Beauty Beneath the Expressway: A Journey from Self to Service
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



